[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349674-105":59,"doc-detail-349674-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomarkers-in-oral-squamous-cell-carcinoma-a-systematic-review","Biomarkers in oral squamous cell carcinoma - A systematic review","","Oral squamous cell carcinoma (OSCC) is an aggressive oral cancer frequently diagnosed at advanced stages, which reduces survival and limits the ability of clinical examination and histopathology to detect early disease and tumor variability. Molecular biomarkers can improve early diagnosis, prognosis, and personalized therapy, especially when integrated with TNM staging. This systematic review evaluates biomarker evidence for OSCC across diagnosis, prognostic value, and therapeutic implications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomarkers-in-oral-squamous-cell-carcinoma-a-systematic-review/349674/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomarkers-in-oral-squamous-cell-carcinoma-a-systematic-review/349674.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are molecular biomarkers important in oral squamous cell carcinoma (OSCC)?","Question",{"text":112,"@type":113},"They can address limitations of clinical examination and histopathology by improving early diagnosis, prognosis, and personalized treatment, particularly when combined with TNM staging information.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the systematic review conducted?",{"text":117,"@type":113},"Studies were identified by searching PubMed, Scopus, and Web of Science for biomarker research in OSCC published between January 2018 and December 2024, using strict inclusion and exclusion criteria focused on diagnosis, prognosis, and therapeutic implications.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biomarkers showed significant associations in the review?",{"text":121,"@type":113},"Key biomarkers including Ki67, HSP60, Survivin, E-cadherin, and PD-L1 were significantly associated with tumor progression, lymph node metastasis, and poor prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349674,1790799136,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Med Oral Patol Oral Cir Bucal. 2026 Jan 1;31 (1):e82-e88 . Biomarkers in oral squamous cell carcinoma  \nJournal section: Oral Medicine and Pathology  \nPublication Types: Review  \nBiomarkers in oral squamous cell carcinoma: A systematic review  \nMónica López-Galindo 1, Margot de Sousa-Roques 2  \ndoi:10.4317/medoral.27565  \n1 Associate Professor. PhD. Dentistry Department. Faculty of Health Sciences. Universidad Europea de Valencia, Spain 2 Dentist graduated from Universidad Europea de Valencia, Spain  \nCorrespondence:  \nCalle Duque de Calabria nº 17, puerta 1 46005-Valencia, Spain [mopauloga@gmail.com](mopauloga@gmail.com)  \n[Received: 02/06/2025](Received: 02/06/2025)  \n[Accepted: 21/07/2025](Accepted: 21/07/2025)  \nLópez-Galindo M, Roques M. Biomarkers in oral squamous cell carcinoma: A systematic review. Med Oral Patol Oral Cir Bucal. 2026 Jan 1;31  \n(1):e82-e88 .  \nArticle Number:27565 [http://www.medicinaoral.com/](http://www.medicinaoral.com/)  \n© Medicina Oral S. L. C.I.F. B 96689336-pISSN 1698-4447-eISSN: 1698-6946 eMail: medicina@medicinaoral.com  \nIndexed in:  \nScience Citation Index Expanded  \nJournal Citation Reports  \nIndex Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español  \nAbstract  \nBackground: Oral squamous cell carcinoma (OSCC) is one of the most aggressive cancers in the oral cavity, often diagnosed at advanced stages, leading to significantly reduced survival rates. Traditional diagnostic methods, such as clinical examination and histopathology, have limitations in detecting early stages and assessing tumor variability. Molecular biomarkers, however, have shown great potential in overcoming these limitations by improving early diagnosis, prognosis, and personalized treatment. These biomarkers, when integrated with the TNM staging system, may provide more accurate and personalized clinical management.  \nMaterial and Methods: A systematic review was conducted by searching PubMed, Scopus, and Web of Science databases for studies on biomarkers in OSCC published between January 2018 and December 2024. The studies were selected based on strict inclusion and exclusion criteria, focusing on those that investigated biomarkers related to OSCC diagnosis, prognosis, and therapeutic implications.  \nResults: This review includes 10 studies involving 1024 patients with OSCC. Key biomarkers such as Ki67, HSP60, Survivin, E-cadherin, and PD-L1 were significantly associated with tumor progression, lymph node metastasis, and poor prognosis. The combined use of these biomarkers with traditional histopathological methods could enhance diagnostic accuracy, allowing for better patient stratification and more targeted treatment approaches. Additionally, saliva-based biomarkers have emerged as a promising, non-invasive diagnostic tool with high sensitivity and specificity for early detection of OSCC.  \nConclusions: The identification of specific biomarkers can significantly enrich the diagnostic, prognostic, and therapeutic management of OSCC, complementing the TNM staging system. These biomarkers are linked to critical clinical variables such as metastasis, survival, and response to treatment. Saliva-based biomarkers hold promise due to their non-invasive nature, but further validation through multicenter studies and standardization is required for their widespread clinical adoption.  \nKeywords: Carcinoma, squamous cell, squamous cell carcinoma, SCC, OSCC, oral squamous cell carcinoma, epidermoid carcinoma, mouth neoplasms, oral cancer, carcinoma oral, cancer oral, biomarkers, biomarker, tumor marker, molecular marker, genetic marker, protein marker, microrna, mirna, epigenetic marker, salivary biomarker, serum biomarker, diagnosis, prognosis, early detection, stratification, therapeutic target, prognostic marker, predictive marker.  \nIntroduction  \nOral squamous cell carcinoma (OSCC) represents about 90% of oral cancers and remains one of the most common cancers in the head and neck region. Despite advances ","cbCaibsvwyr0NSCr","https://ap.wps.com/l/cbCaibsvwyr0NSCr","pdf",468247,"English","# Abstract\n## Background\n## Material and Methods\n## Results\n## Conclusions\n# Introduction\n# Material and Methods","[{\"question\":\"Why are molecular biomarkers important in oral squamous cell carcinoma (OSCC)?\",\"answer\":\"They can address limitations of clinical examination and histopathology by improving early diagnosis, prognosis, and personalized treatment, particularly when combined with TNM staging information.\"},{\"question\":\"How was the systematic review conducted?\",\"answer\":\"Studies were identified by searching PubMed, Scopus, and Web of Science for biomarker research in OSCC published between January 2018 and December 2024, using strict inclusion and exclusion criteria focused on diagnosis, prognosis, and therapeutic implications.\"},{\"question\":\"Which biomarkers showed significant associations in the review?\",\"answer\":\"Key biomarkers including Ki67, HSP60, Survivin, E-cadherin, and PD-L1 were significantly associated with tumor progression, lymph node metastasis, and poor prognosis.\"}]","Biomarkers in oral squamous cell carcinoma - A systematic review | PDF",1790084973,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7590c41feaf2c87b381490cf09145fff.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d56ead8d6ff6136d79bb615a43730bf.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a0f17834b594d7bfcb6e5c9171b8a1b.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eae2e580393acc9ca4bf35958e66d178.webp",980,1306]